Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yip boring, watching lnux and other try for new hodz
just like I tried to warn about here and newsletter, let the process work itself thru
NEOL- look for those dips
lnux-trying to make a run for it, sticking to $4-6 target in a few weeks
Implant Sciences Demands Halting of Trading of Its Common Stock on Berlin-Bremen Stock Exchange
Wednesday June 30, 9:46 am ET
WAKEFIELD, Mass.--(BUSINESS WIRE)--June 30, 2004--Implant Sciences Corporation (AMEX: "IMX", "IMX.WS") a developer and manufacturer of products for national security, medicine and industry, today announced that it has learned that its common stock has been listed on the Berlin-Bremen Stock Exchange without the Company's prior knowledge, consent or authorization.
The Company, through its counsel, has contacted the Berlin-Bremen Stock Exchange and has demanded an immediate halt to trading in Implant Sciences stock.
Dr. Anthony J. Armini, CEO and Chairman of Implant Sciences, commented: "We did not apply for this listing on the Berlin-Bremen Stock Exchange or any other exchange in Germany. We were not consulted or contacted by anyone at the Exchange, either before or after we were listed, and we certainly did not request or consent to the listing. We have no interest in trading on the Berlin-Bremen Stock Exchange, or any other Exchange that could cause the Company's common stock to be traded in an environment that can lend itself to manipulation. Furthermore, we are quite disturbed at the media reports that brokers have been using such listing as a mechanism for manipulating the price of U.S. stocks. Therefore, our attorneys have demanded an immediate end to trading and immediate removal of the listing of our common stock from the Berlin-Bremen Stock Exchange."
Dr. Armini further added, "We believe we are building real value in the Company, and Management will take action to protect the interests of our shareholders. I want our shareholders to know that we take the matter of the unauthorized listing of our stock on the Berlin-Bremen Stock Exchange very seriously, and we will remain vigilant against any future efforts to undermine the integrity of our stock."
About Implant Sciences
Implant Sciences, incorporated in 1984, is using its core ion technology to develop, manufacture and market products for national security, medicine, and industry. Under development are portable and bench-top trace element detection devices to identify explosives, narcotics and other toxic materials. The Company has also received government grants from the US Army, Navy and Air Force, and the Transportation Security Administration to adapt the Company's explosive detection technology to a wide number of security requirements.
Using its proprietary ion implantation and thin film coating technologies, Implant Sciences has a sophisticated production line that modifies the surface characteristics of orthopedic joint implants to reduce polyethylene wear, thereby substantially increasing the life of the implants. The company also manufactures and markets radioactive and non-radioactive products for medical use, including radioactive seeds for treating prostate cancer that are distributed throughout the United States by its own direct sales force. In parallel with the production of these seeds, it is also developing additional brachytherapy products for the treatment of breast, eye, and other cancers.
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, the ability to fund and consummate an accretive acquisition, the ability of the Company to develop effective new products and receive governmental approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
--------------------------------------------------------------------------------
Contact:
Implant Sciences Corporation:
David C. Volpe, 508-523-3141
dvolpe@implantsciences.com
www.implantsciences.com
or
Investor contact:
Aurelius Consulting Group:
Dave Gentry, 407-644-4256
dave@aurcg.com
www.runonideas.com
or
Media contact:
The Investor Relations Group
Mike Graff or Janet Vasquez
212-825-3210
good morning- looks like shooting fish in a bucket markets are here. :)
caveator- thanks good to know :)
he is a good trader, and I do not like to see people banned,,,, isnt that why magic and mflutie opened this board? Maybe I am out of line, but it did play a role in splitting up another board.
any thoughts about today being end of Q?
odd stocks off higher creeper scan- very low vol for most. I rarely run this scan
PEGA Pegasystems, Inc. (PEGA) 8.35
SUNH Sun Healthcare Group Inc. (SUNH) 9.10
HWKN Hawkins Chemical, Inc. (HWKN) 11.90
PER Perot Systems Corp. (PER) 13.33
DMH Ducati Motor Holding S.p. (DMH) 14.55
neol, 11,12,13,14,15,16,17,18,19- you get the idea
he should demand a refund from matt.
neol- closed at the hod :)
NR- made its move at the bell
lierod- I have lost track of this person- dont have an email address. Anyone?
C- late day spray paint up
im sorry- I guess I mis understood you- and as for GEB- you will be happy soon. Grow too.
you mean to tell me, that me talking to myself is more than what is going on in chat? Good grief- I will shut up to turn those stats around -lol
more likely a short program hit markets awhile ago-naz dipped to +6,, maybe +2- I missed it... Anyway a long hedgefund sold into yesterdays pop- no buyers left in certain areas of the markets,, still anybody watching C+ MSFT or the vix or the $usd, or anything, under currents? Nope- I guess not.
I dont short either- but am working on that,,training my brain-lol, I dont charge at all for 'short' scans- cant see a reason to charge for an 'in progress' thing.
But mostly what got my attention was that very nice climb that lxrs had-and I hope your gbel does the same- go up. :)
ngen- I posted early and many times- if you lost $, well I dont know what to tell you. Bushin the doghouse- yip, not right-imho
this board is just as quiet as if the market were red- well glad my paid thing here will expire soon.
watch for shorting op-give them a day or 2 to top if un-sure:
ABS Albertsons, Inc. (ABS) 26.42
CCE Coca Cola Enterprises, Inc. (CCE) 29.01
EIX Edison Intl, Inc. (EIX) 25.43
JAKK JAKKS Pacific, Inc. (JAKK) 20.56
KFY Korn Ferry Intl (KFY) 19.26
RRD Donnelley R R & Sons Co. (RRD) 32.98
List Notes: I have no position in any of them.
reggie- while working on a scan for good stocks toshort- still working on - (it goes against my nature) I found a stock that finally fell- LXRS- I posted it somewhere else friday or so. anyway- check out that 6 month climb and today it fell.
NEOL- bush I hope you bought the calls :)
gold- ouch! lol
anybody ever watch C+MSFT?
$usd+.50,, gold-$5.0+/-
NEOL- bio/pharms wont need a green market- shorts will/are starting to cover- high r/r pay off
nr- should have a nice move soon, stkl, wondering about another test of 9, glbl-laggard-it will wake up
asia-been pounding table on china stocks
quiet board today- be back later.
grow- it means they have their ducks in a row, alot more than other brokers, etc.. A true value/growth story. Street will find them someday- they have to- they keep kicking butt for their clients on rate of return, and apparently new clients and cash handling have made it fairly easy to knock out debt. Still long, just tucking away. I am trying to get my parents to move some of their Ira stuff over to the grow gang to take some stuff off of my plate. I really like their fund USCOX for the next year or so.
ELN-Elan Announces Repayment by EPIL II of $450 Million Notes at Maturity
Tuesday June 29, 2:30 am ET
DUBLIN--(BUSINESS WIRE)--June 29, 2004--Elan Corporation, plc announced today the repayment by Elan Pharmaceutical Investments II, Ltd. (EPIL II) of the $450.0 million guaranteed notes which were issued on June 28, 2000 and matured on June 28, 2004 together with accrued interest for the period from December 31, 2003 to June 28, 2004 of $21.5 million. Of the aggregate payment of $471.5 million, $79.7 million was funded from the cash resources in EPIL II and through the sale of EPIL II's entire investment portfolio. The balance of $391.8 million was funded by Elan under its guarantee and will result in a charge in the second quarter of 2004 of $33.4 million, consisting of interest of $10.8 million and investment losses of $22.6 million.
Elan's cash balances at June 28, 2004, after making the payment under the guarantee, exceeded $670 million and Elan's debt position has been reduced to approximately $1.5 billion, approximately $1.1 billion of which is not due until 2008.
About Elan
Elan is focused on the discovery, development, manufacturing, sale and marketing of novel therapeutic products in neurology, severe pain and autoimmune diseases. Elan (NYSE:ELN - News) shares trade on the New York, London and Dublin Stock Exchanges.
--------------------------------------------------------------------------------
Contact:
Elan
Investors:
Emer Reynolds, 353-1-709-4000
800-252-3526
or
Media:
Anita Kawatra, 212-407-5755
800-252-3526
--------------------------------------------------------------------------------
Source: Elan
80+mph avg, bbbbbbbbbbbllllllll, wake me in the morning :),, I did get a scan listed, no notes :)
thanks stockpup- back in town- groggy, just 'sort of catching up on the day' I see idnx was wiggly. Or something,, alot of posts on it.
awsome day in the markets today- I will be gone for several days- you guys have great trading.-i'll miss it, but my eyes can use a break from the digital world.
NEOL- late day big bidder came in to cover on old bad news.
asia moving- watch your china stocks
Russell and Nomura Introduce "Prime Index"
Newly developed index suitable for passive investment
June 23, 2004 — Russell Investment Group, headquartered in Tacoma, Washington, USA and Nomura Securities Co., Ltd., headquartered in Tokyo, Japan, have developed a new Japan stock index, the RUSSELL/NOMURA Prime Index, which is well-suited as an underlying model for passive investment of Japanese equity.
In 1995, Russell and Financial & Economic Research Center of Nomura Securities Co., Ltd. (formerly Nomura Research Institute) jointly developed a family of Japan equity indexes, the RUSSELL/NOMURA Japan Indexes, which have been used by a broad range of investors as the first Japan equity indexes that provide both style indexes and adjustment for float (shares available for trading). The RUSSELL/NOMURA Japan indexes are frequently used as style benchmarks for evaluating the performance of small-cap, value, or growth investment strategies. This new index, RUSSELL/NOMURA Prime Index, as a member of the RUSSELL/NOMURA Japan Index family, is designed for passive investment strategies, which aim to closely track the performance of the underlying index. Listings of futures and exchange-traded funds (ETFs) also are anticipated.
The following are key characteristics of the RUSSELL/NOMURA Prime Index: It represents Japan's top 1,000 stocks, determined by float-adjusted market capitalization.
It includes stocks from a broad universe of Japan equities, including those listed on JASDAQ, and does not limit membership to the first section of Tokyo Stock Exchange.
It adjusts index membership for float, or those shares that are available for trading.
It employs "banding" methods when membership is rebalanced at the annual reconstitution in order to control the frequent replacement caused by small fluctuations of market capitalization. Also, a "negative-list" method is used to manage the inclusion of stocks of especially low liquidity.
It continuously includes stocks that are tentatively unlisted due to mergers or equity transfers.
About Russell
Russell Investment Group, a global leader in multi-manager investing, provides investment products and services in more than 35 countries. Russell manages more than $100 billion in assets and advises clients worldwide representing more than $1.8 trillion. Founded in 1936, Russell is a subsidiary of Northwestern Mutual and is headquartered in Tacoma, Wash., with additional offices in New York, Toronto, London, Paris, Singapore, Auckland and Tokyo.
Contact Information
Russell Investment Group
US — Steve Claiborne, manager, Media Relations
Tel 253-594-1858
E-mail newsroom@russell.com
Japan — Mayumi Ohata, Marketing & Communications
Tel 81-3-5411-3538
E-mail Tokyo-FR@russell.com
Financial & Economic Research Center
Nomura Securities Co., Ltd.
Tel 81-3-3274-0924
E-mail: idx_mgr@ms.frc.nomura.co.jp
RC 4218
Copyright © Frank Russell Company 2004. All rights reserved.